Literature DB >> 20956010

Influenza virus genome C4 promoter/origin attenuates its transcription and replication activity by the low polymerase recognition activity.

Hongbing Jiang1, Shijian Zhang, Qiang Wang, Jinlan Wang, Liqing Geng, Tetsuya Toyoda.   

Abstract

A natural variation is observed at position 4 of the 3'-end of influenza A virus genomes, where U (U4) or C (C4) is present. The replicon activity of C4 was 28% of U4. We compared the transcription and replication activity of U4 [v84(U4)], C4 [v84(C4)] and the complimentary RNA (c84) using the purified influenza virus RNA polymerase in vitro. ApG-primed replication activities of v84(C4) and c84 were 23.8% and 7.8% of v84(U4). Globin mRNA-primed transcription activities of v84(C4) and c84 were 36.9% and 6.81% of v84(U4). De novo replication activities of v84(C4) and c84 were 21.3 and 10.2% of v84(U4). This difference came from their polymerase binding activity. When all the eight genome segments of WSN strain were changed to U4, the virus titer was 760 times higher than the wild type. However, its pathogenicity in mice was lower than the wild type.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956010     DOI: 10.1016/j.virol.2010.09.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Rapid sequencing of influenza A virus vRNA, cRNA and mRNA non-coding regions.

Authors:  Ruixue Wang; Yongli Xiao; Jeffery K Taubenberger
Journal:  J Virol Methods       Date:  2013-10-04       Impact factor: 2.014

2.  A novel small-molecule binds to the influenza A virus RNA promoter and inhibits viral replication.

Authors:  Mi-Kyung Lee; Angel Bottini; Meehyein Kim; Michael F Bardaro; Ziming Zhang; Maurizio Pellecchia; Byong-Seok Choi; Gabriele Varani
Journal:  Chem Commun (Camb)       Date:  2013-11-18       Impact factor: 6.222

3.  PA from an H5N1 highly pathogenic avian influenza virus activates viral transcription and replication and induces apoptosis and interferon expression at an early stage of infection.

Authors:  Qiang Wang; Shijian Zhang; Hongbing Jiang; Jinlan Wang; Leiyun Weng; Yingying Mao; Satoshi Sekiguchi; Fumihiko Yasui; Michinori Kohara; Philippe Buchy; Vincent Deubel; Ke Xu; Bing Sun; Tetsuya Toyoda
Journal:  Virol J       Date:  2012-06-08       Impact factor: 4.099

4.  U4 at the 3' UTR of PB1 segment of H5N1 influenza virus promotes RNA polymerase activity and contributes to viral pathogenicity.

Authors:  Wei Sun; Jing Li; Pengfei Han; Yinhui Yang; Xiaoping Kang; Yuchang Li; Jiaming Li; Yu Zhang; Xiaoyan Wu; Tao Jiang; Chengfeng Qin; Yi Hu; Qingyu Zhu
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

5.  Development of high-yield influenza A virus vaccine viruses.

Authors:  Jihui Ping; Tiago J S Lopes; Chairul A Nidom; Elodie Ghedin; Catherine A Macken; Adam Fitch; Masaki Imai; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nat Commun       Date:  2015-09-02       Impact factor: 14.919

6.  Effect of the fourth nucleotide at the 3' end of neuraminidase and matrix viral genomic RNA on the pathogenicity of influenza virus A/PR/8/34.

Authors:  Chung-Young Lee; Hyuk-Joon Kwon; Thanh Trung Nguyen; Ilhwan Kim; Hyung-Kwan Jang; Jae-Hong Kim
Journal:  J Vet Sci       Date:  2017-08-31       Impact factor: 1.672

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.